SPDR SERIES TRUST SPDR S&P BIOTECH ETF (XBI) - Price, trends, fundamentals and chart - Passport to Wall Street

SPDR SERIES TRUST SPDR S&P BIOTECH ETF (AMEX: XBI)

Overview

current price

$94.30

$94.30

change

0.00 | 0.00%

0.00 | 0.00%

Yesterday's Close

94.30

open

0.00

volume

0.00 M

30d. avg volume.

8.90 M

1 day

0.00 - 0.00

52 weeks

71.99 - 105.47

p/e

0.00

beta

0.9406

market cap

6.78 B

dividend yield

0.15%

Industry

-

News and Commentary

Why Investors Should Pay Attention to the Biotech, Genomics Sectors Given the market's strong bull market and massive gains off the March 2020 lows, there has been a dearth of opportunities for investors for much of the past couple of years. Now,...

Here’s Why Investors Should Consider Biotech, Pharmaceutical Stocks The financial markets are not the most pleasant and calm place right now. It's facing risks in multiple areas such as geopolitics, inflation, and economic growth. There's also th...

Biotech ETFs May Need to Prepare for More Losses Ahead Biotechnology stocks faced their worst April on record, and more pain may be ahead for biotech-focused exchange traded funds (ETF).Popular biotech-focus...

Moderna Vaccine Update May Boost Biotech ETFs Moderna (MRNA

ETF Weekly: Industry Leaders Discuss 2020 Trends at Inside ETFs As exchange-traded fund industry leaders are meeting for the Inside ETFs, the world's largest ETF conference, this week, let's take a look at the latest trends that will be discu...

Neuro Drug Stocks Rise Following Intra-CellularTherapies' Drug Approval One indisputable trend about the modern world is that people are living longer. In 1950, the average lifespan for an American was 68 years old. Today, it's 78. One result of a lo...

ETF Weekly: Ways to Invest in Saudi Aramco Saudi Aramco may have debuted on the country's own stock exchange last Monday, but investing it the world's most highly-valued company has not yet become available to American ma...

Top-Down Analysis of Markets The markets have moved into the final stages of the first quarter, all with gains to report. Today we go over all the different areas to see how things are going.

StockTwits

StockTwits

Join now and unlock premium features

Access to premium stock and ETF data including financials, holdings and more
Participate in trading contests and earn real prizes
Sync you favorite articles and symbols between all of your device
And much more